Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chronic Pain × ziconotide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pain 2 Neuralgia 2 Neoplasms 2 Wounds and Injuries 1 Peripheral Nervous System Diseases 1 Pain, Intractable 1 Lymphoma, Follicular 1 HIV Infections 1 Chronic Pain 1 Bronchiolitis Obliterans Syndrome 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Complex 1

Interventions

Morphine 7 Surveys and Questionnaires 6 Ketamine 4 Sodium Chloride 3 Saline Solution 3 Fentanyl 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 Pregabalin 2 Lidocaine 2 Control Groups 2 Acetaminophen 2 ziconotide 1 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Tramadol 1 Telemedicine 1 Tapentadol 1 Tamoxifen 1 Standard of Care 1 Spinal Cord Stimulation 1 Sound Recordings 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06541184 2025-02-27

Ziconotide for Non-cancer Pain by Intrathecal Administration

ESTEVE Pharmaceuticals SAS

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡